Cellectis (CLLS) Revenue (2015 - 2026)

Cellectis (CLLS) posted quarterly Revenue of $5.8 million for Q1 2026, down 45.78% year-over-year from $10.7 million in Q1 2025, and down 54.57% quarter-over-quarter from $12.7 million in Q4 2025.

Cellectis (CLLS) Revenue (2015 - 2026) Analysis & Trends

Cellectis' Revenue history runs 12 years deep, the most recent figure standing at $5.8 million for Q1 2026.

  • In Q1 2026, Revenue fell 45.78% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $70.4 million (up 27.19% YoY), while the FY2025 annual figure was $72.9 million, up 48.22% from the prior year.
  • Revenue for Q1 2026 stood at $5.8 million, down from $12.7 million in the prior quarter.
  • The five-year high for Revenue was $35.2 million in Q3 2025, with the low at $139000.0 in Q1 2023.
  • The 5-year median for Revenue is $8.1 million (2024), against an average of $9.3 million.
  • The sharpest annual moves came in 2022 and 2024: Revenue slumped 97.89% in 2022, then jumped 10351.61% in 2024.
  • Cellectis' Revenue stood at $16.0 million in 2022, then sank by 45.58% to $8.7 million in 2023, then jumped by 134.24% to $20.4 million in 2024, then slumped by 37.75% to $12.7 million in 2025, then sank by 54.57% to $5.8 million in 2026.
  • Business Quant data shows CLLS's Revenue at $5.8 million in Q1 2026, $12.7 million in Q4 2025, and $35.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Cellectis 306.61 Mn 120.95 Mn - 5.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.78 Mn
Dec 31, 2025 12.72 Mn
Sep 30, 2025 35.17 Mn
Jun 30, 2025 16.73 Mn
Mar 31, 2025 10.66 Mn
Dec 31, 2024 20.43 Mn
Sep 30, 2024 16.20 Mn
Jun 30, 2024 8.06 Mn
Mar 31, 2024 4.53 Mn
Dec 31, 2023 8.72 Mn
Sep 30, 2023 155,000.00
Jun 30, 2023 178,000.00
Mar 31, 2023 139,000.00
Dec 31, 2022 16.02 Mn
Sep 30, 2022 175,000.00
Jun 30, 2022 1.31 Mn
Mar 31, 2022 1.67 Mn
Dec 31, 2021 10.26 Mn
Sep 30, 2021 8.31 Mn
Jun 30, 2021 11.18 Mn